This hyper-focus on cutting-edge AI and the “next big thing” poses a dilemma for many entrepreneurs: There is more pressure ...

Friday’s jobs report could bolster the view that the American economy is holding steady, but an oil price shock could ...

When you think of health care, what do you picture? Many of us see doctors in white coats and nurses wearing scrubs, but we don’t think of the people behind the scenes who ensure everything runs ...

As the Department of Health and Human Services considers how to regulate artificial intelligence in the multibillion-dollar health care sector, Pulse spoke with one of the agency’s leading AI policy ...

Heart disease is a type of cardiovascular disease that affects the heart’s structure and function. Several different heart ...

The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...

NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

Shares of Hims & Hers (NYSE: HIMS) fell as much as 15% on Thursday after news that Eli Lilly's (NYSE: LLY) GLP-1 drug was taken off the shortage list by the FDA. This could impact Hims & Hers' GLP ...